Recursion Pharmaceuticals is listed on Nasdaq, and BioCardia, Inc. is a company developing therapeutics in the United States.

The entities involved

• Recursion (United States) →

  company in Salt Lake City, United States

  • Recursion (United States) disclosed insider trading via required filings with the SEC on June 6, 2026.Sun 17:12
  • Trump's pledge to unleash oil and gas benefits stocks, involving Willis Towers Watson.Sun 05:14
• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28

Related events

• MarketBeat is providing analyst ratings for Recursion Pharmaceuticals.Sep 20
• Cardiol Therapeutics Inc. is listed on Nasdaq and is developing therapy for an FDA-approved indication.Wed 10:43
• Generate Biomedicines Inc listed its shares on the Nasdaq stock exchange on August 25, 2026.Aug 25
• Decoy Therapeutics is listed on the Nasdaq stock exchange and is currently seeking expedited regulatory approval via FDA pathways.Sep 22
• Decoy Therapeutics was listed on the Nasdaq stock exchange on September 22, 2026.Tue 18:38